Products for Research Use Only
RegisterLogin

Trastuzumab deruxtecan

CAT: 1410-M34869-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M34869-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd) . Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
CAS Number
1826843-81-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 45.42 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antibody-Drug Conjugates (ADCs)

Related Products

CatalogName
M26662-01Deruxtecan
M35147-01Datopotamab deruxtecan
M22143-01Trastuzumab

Alternative Products

CatalogName
T36646-01Trastuzumab deruxtecan
GTR18338067-01Trastuzumab deruxtecan Antibody
DHC09698Trastuzumab deruxtecan (ADC)
HY-138298-01Trastuzumab deruxtecan (solution)
JH913995Trastuzumab deruxtecan (Enhertu)
B23603201-01Anti-Human Her2 (Trastuzumab Deruxtecan)
ICH4013D-1mgTrastuzumab Deruxtecan Biosimilar - Research Grade
C01150-01Trastuzumab-deruxtecan (DS-8201a, T-DXd)
D4001-01Trastuzumab deruxtecan (DS-8201a, T-DXd)
F1402-1Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab deruxtecan)

Popular Products